Feniralstat

N/A

Report date: 2026/05/07 20:00:36
NME

Base Information

Drug NameFeniralstat
Drug Alias NameKVD-824
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPlasma kallikrein inhibitors
TargetsPlasma kallikrein
Therapy Area/IndicationsHereditary Angioedema Types I and IIAngioedemas, Hereditary
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaBulgariaCanada +[13] 
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesVantia Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesKalvista Pharmaceuticals Ltd
Active IndicationsN/A
Inactive IndicationsHereditary Angioedema Types I and IIAngioedemas, Hereditary

Other Information

ATC CodeN/A
Related LinksKEGG